Pre-Operative MRI Effective in Women with Dense Breasts
| By HospiMedica International staff writers Posted on 11 Nov 2020 | 
			
			Pre-operative MRI can catch more breast cancer lesions in women with dense breasts who receive an initial diagnosis via digital breast tomosynthesis (DBT), according to a new study.
Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.
The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.
“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Pennsylvania
		
			
			
		
        		        
		        Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.
The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.
“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Pennsylvania
Latest MRI News
Channels
Critical Care
view channel 
                    Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
Monitoring blood flow in the brain is crucial for diagnosing and treating neurological conditions such as stroke, traumatic brain injury (TBI), and vascular dementia. However, current imaging methods like... Read more 
                    AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
For decades, doctors have relied on standardized scoring systems to assess patients with the most common type of heart attack—non-ST-elevation acute coronary syndrome (NSTE-ACS). The GRACE score, used... Read moreSurgical Techniques
view channel 
                    Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more 
                    Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read morePatient Care
view channel 
                    Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more 
                    VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more 
                    Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more 
                    First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel 
                    Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel 
                    Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more 
                    B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more 
                    CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more 
                    















 
								

 
								
 
								 
                     
                     
                     
                     
                    